Using a rat model of permanent cerebral ischemia, pretreatment with a TNF-α receptor antagonist, R-7050, provided protection against poststroke neurological deficits, brain infarction, edema, oxidative stress, and caspase 3 activation. The gene discussed is CASP3; the disease is brain infarction.